Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029
Published Date : 30-Apr-2023 |
Pages: 220 |
Formats: PDF |
COVID-19 Impact on the Anti-Obesity Drugs Market
Market Overview
The Global Anti-Obesity Drugs Market size is expected to reach $3.1 billion by 2029, rising at a market growth of 10.6% CAGR during the forecast period.
Obesity is a medical disease in which the body's extra body fat has built up to the point that it could be harmful to one's health. Carrying a body mass index (BMI) of 30 or more is the standard definition. It is largely acknowledged as the most significant and rapidly expanding public health issue in both industrialized and developing nations. Anti-obesity medications are ones that doctors prescribe to help the overweight. These medications reduce hunger, boost metabolism, or prevent the absorption of fat from meals.
Phentermine, liraglutide, sibutramine, and orlistat, are a few of the anti-obesity medications that are frequently recommended. The significant increase in the prevalence rate of obesity, the rise in the health risks associated with being overweight or obese, and the rise in the volume of research and development operations for multiple potential drug molecules to combat both obesity and type 2 diabetes mellitus by key market players are the main factors driving the growth of the anti-obesity drugs market share.
The expansion of clinical studies for the treatment of obesity is anticipated to fuel demand for anti-obesity medications. For instance, large corporations are creating prospective medicine substitutes to enhance the scenario for treating obesity. One of the main reasons projected to promote the growth of the anti-obesity drug market share is the increase in R&D activity among key players for the creation of anti-obesity treatments with fewer adverse effects.
As the obesity rate rises, the market's leading companies are also creating new products and gaining market acceptance. Due to the rising demand for long-lasting medications, it is anticipated that the opportunities for market vendors to create new products will increase significantly. Numerous industry experts and suppliers have been conducting research on medications that can treat both type II diabetes and obesity as a result of the increased prevalence of the disease. This aspect is anticipated to support market expansion eventually.
COVID-19 Impact Analysis
The negative effects on the market have been reduced by the rising use of telemedicine in place of "in-person" hospital visits and the use of internet pharmacies to buy repeat prescription drugs. Additionally, pharmaceutical firms put a lot of effort into keeping the pandemic's supply and demand in check to sustain their profits. Due to the rapid weight gain people experience when sitting at home or working from home, the sudden development of the COVID-19 virus has later raised the need for anti-obesity treatments. In addition, it is anticipated that forthcoming product launches, major pipeline opportunities at well-known companies, and a continuing rise in obesity will all contribute to the market's significant growth potential in the post COVID-19 period, after facing a decline in the starting phase.
Market Growth Factors
The growth of fast-food industry and increasing consumption of unhealthy food
The fast-food industry has experienced a significant increase in consumption. Frequent consumption of fast food has been associated with obesity and allergies. Consuming fast food can increase the risk of health issues such as bloating, stomach ulcers, and potentially even stomach cancer due to the presence of harmful substances, chemicals, and excessive salt. Increased salt intake from fast food can lead to water retention in the body, potentially causing discomforts such as stomach pain and abdominal bloating. The correlation between fast food consumption among adults and wealth is positive, while it is negative with age. This is expected to increase the demand for anti-obesity drugs, surging the market growth.
Enhancing pharmaceutical research and development
The success of a new pharmaceutical product in generating long-term profits is contingent upon the pricing strategy implemented by companies across various regions, the projected sales volume at those prices, and the probability of a successful drug development process, which significantly impacts research and development expenses. In addition, government programs and policies significantly influence the pharmaceutical industry's private spending for research and development. This impact is achieved through diverse methods, including boosting the need for prescribed medications, financing fundamental research, overseeing clinical trials, and issuing vaccine guidance that impacts both supply and demand.
Market Restraining Factors
Lack of awareness and adoption of medication
The fitness industry is rapidly evolving with a growing ecosystem comprising customers, equipment and service suppliers, complementary sectors, and public programs. There is a growing trend among individuals to prioritize fitness and monitor their daily routines and habits. The fitness industry is evolving and becoming more dynamic due to globalization and the easy accessibility of knowledge. This enhances and reinforces traditional practices and exercises. Also, gyms and other natural ways are being preferred to lose weight by the general population as there is a lack of awareness regarding anti-obesity drugs, which is expected to hinder the anti-obesity drugs market growth during the projected period.
Drug Type Outlook
Based on drug type, the anti-obesity drugs market is segmented into prescription drugs and over the counter drugs. The prescription drugs segment dominated the anti-obesity drugs market with maximum revenue share in 2022. The growth is attributed due to the presence of established players who have obtained regulatory approval for their products. These enterprises are promoting the acceptance for such commodities by enhancing their investment in research and development programs and forming strategic alliances to launch efficient remedies.
Mechanism of Action Outlook
On the basis of mechanism of action, the anti-obesity drugs market is divided into centrally acting anti-obesity drugs and peripherally acting anti-obesity drugs. The peripherally acting segment procured a substantial revenue share in the anti-obesity drugs market in 2022. This is because peripherally acting anti-obesity agents refer to pharmaceuticals that aid in weight reduction without impacting the brain or appetite suppression. This product functions as a pancreatic lipase inhibitor, effectively impeding the breakdown of fat in the gastrointestinal tract and ultimately leading to a reduction in the absorption of fat in the intestines.
Route of Administration Outlook
By route of administration, the anti-obesity drugs market is classified into oral route and subcutaneous route. The oral route segment witnessed the largest revenue share in the anti-obesity drugs market in 2022. This is because oral drug delivery is a highly preferred administration route for the anti-obesity drug due to its noninvasive nature, high patient compliance, ease of handling, and lack of requirement for specific sterile conditions. Various types of nanoparticles (NPs), hydrogels, microparticles, or combinations of them have been employed to enhance bioavailability or target specificity in the gut.
Distribution Channel Outlook
Based on the distribution channel, the anti-obesity drugs market is bifurcated into hospital pharmacies, retail pharmacies and online pharmacies. The online pharmacies segment recorded a significant revenue share in the anti-obesity drugs market in 2022. This is due to the rise in e-pharmacy usage, which has led to greater accessibility of anti-obesity medication for patients, streamlining the drug procurement process. In addition, the chronic condition of obesity requires the patient to obtain a refill in order to maintain the long-term treatment plan. This can lead to increased utilization of anti-obesity medications through online pharmacy distribution channels, driving the segment's growth during the projected period.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 1.5 Billion |
| Market size forecast in 2029 | USD 3.1 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2029 |
| Revenue Growth Rate | CAGR of 10.6% from 2023 to 2029 |
| Number of Pages | 220 |
| Number of Table | 410 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Drug Type, Mechanism of Action, Route of Administration, Distribution Channel, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Regional Outlook
Region-wise, the anti-obesity drugs market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region led the anti-obesity drugs market by generating the maximum revenue share in 2022. The growth of the anti-obesity drugs market in the region is primarily fueled by the rise in the number of individuals who are obese and the significant healthcare spending on anti-obesity drugs. Moreover, the market growth is anticipated to be driven by the heightened awareness among the populace regarding the grave chronic ailments associated with obesity and the surge in clinical trials due to increased investment by major industry players in research and development endeavors.
Free Valuable Insights: Global Anti-Obesity Drugs Market size to reach USD 3.1 Billion by 2029
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Pfizer, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Novo Nordisk A/S, Rhythm Pharmaceuticals, Inc., Gelesis Holdings Inc. (PureTech Health), Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Vivus LLC, CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) and KVK Tech, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Drug Type
- Prescription Drugs
- Over The Counter Drugs
By Mechanism of Action
- Centrally Acting
- Peripherally Acting
By Route Of Administration
- Oral Route
- Subcutaneous Route
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Pfizer, Inc.
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Novo Nordisk A/S
- Rhythm Pharmaceuticals, Inc.
- Gelesis Holdings Inc. (PureTech Health)
- Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
- Vivus LLC
- CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
- KVK Tech, Inc.
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Anti-Obesity Drugs Market, by Drug Type
1.4.2 Global Anti-Obesity Drugs Market, by Mechanism of Action
1.4.3 Global Anti-Obesity Drugs Market, by Route Of Administration
1.4.4 Global Anti-Obesity Drugs Market, by Distribution Channel
1.4.5 Global Anti-Obesity Drugs Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Anti-Obesity Drugs Market by Drug Type
3.1 Global Prescription Drugs Market by Region
3.2 Global Over The Counter Drugs Market by Region
Chapter 4. Global Anti-Obesity Drugs Market by Mechanism of Action
4.1 Global Centrally Acting Market by Region
4.2 Global Peripherally Acting Market by Region
Chapter 5. Global Anti-Obesity Drugs Market by Route Of Administration
5.1 Global Oral Route Market by Region
5.2 Global Subcutaneous Route Market by Region
Chapter 6. Global Anti-Obesity Drugs Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region
Chapter 7. Global Anti-Obesity Drugs Market by Region
7.1 North America Anti-Obesity Drugs Market
7.1.1 North America Anti-Obesity Drugs Market by Drug Type
7.1.1.1 North America Prescription Drugs Market by Country
7.1.1.2 North America Over The Counter Drugs Market by Country
7.1.2 North America Anti-Obesity Drugs Market by Mechanism of Action
7.1.2.1 North America Centrally Acting Market by Country
7.1.2.2 North America Peripherally Acting Market by Country
7.1.3 North America Anti-Obesity Drugs Market by Route Of Administration
7.1.3.1 North America Oral Route Market by Country
7.1.3.2 North America Subcutaneous Route Market by Country
7.1.4 North America Anti-Obesity Drugs Market by Distribution Channel
7.1.4.1 North America Hospital Pharmacies Market by Country
7.1.4.2 North America Retail Pharmacies Market by Country
7.1.4.3 North America Online Pharmacies Market by Country
7.1.5 North America Anti-Obesity Drugs Market by Country
7.1.5.1 US Anti-Obesity Drugs Market
7.1.5.1.1 US Anti-Obesity Drugs Market by Drug Type
7.1.5.1.2 US Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.1.3 US Anti-Obesity Drugs Market by Route Of Administration
7.1.5.1.4 US Anti-Obesity Drugs Market by Distribution Channel
7.1.5.2 Canada Anti-Obesity Drugs Market
7.1.5.2.1 Canada Anti-Obesity Drugs Market by Drug Type
7.1.5.2.2 Canada Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.2.3 Canada Anti-Obesity Drugs Market by Route Of Administration
7.1.5.2.4 Canada Anti-Obesity Drugs Market by Distribution Channel
7.1.5.3 Mexico Anti-Obesity Drugs Market
7.1.5.3.1 Mexico Anti-Obesity Drugs Market by Drug Type
7.1.5.3.2 Mexico Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.3.3 Mexico Anti-Obesity Drugs Market by Route Of Administration
7.1.5.3.4 Mexico Anti-Obesity Drugs Market by Distribution Channel
7.1.5.4 Rest of North America Anti-Obesity Drugs Market
7.1.5.4.1 Rest of North America Anti-Obesity Drugs Market by Drug Type
7.1.5.4.2 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.4.3 Rest of North America Anti-Obesity Drugs Market by Route Of Administration
7.1.5.4.4 Rest of North America Anti-Obesity Drugs Market by Distribution Channel
7.2 Europe Anti-Obesity Drugs Market
7.2.1 Europe Anti-Obesity Drugs Market by Drug Type
7.2.1.1 Europe Prescription Drugs Market by Country
7.2.1.2 Europe Over The Counter Drugs Market by Country
7.2.2 Europe Anti-Obesity Drugs Market by Mechanism of Action
7.2.2.1 Europe Centrally Acting Market by Country
7.2.2.2 Europe Peripherally Acting Market by Country
7.2.3 Europe Anti-Obesity Drugs Market by Route Of Administration
7.2.3.1 Europe Oral Route Market by Country
7.2.3.2 Europe Subcutaneous Route Market by Country
7.2.4 Europe Anti-Obesity Drugs Market by Distribution Channel
7.2.4.1 Europe Hospital Pharmacies Market by Country
7.2.4.2 Europe Retail Pharmacies Market by Country
7.2.4.3 Europe Online Pharmacies Market by Country
7.2.5 Europe Anti-Obesity Drugs Market by Country
7.2.5.1 Germany Anti-Obesity Drugs Market
7.2.5.1.1 Germany Anti-Obesity Drugs Market by Drug Type
7.2.5.1.2 Germany Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.1.3 Germany Anti-Obesity Drugs Market by Route Of Administration
7.2.5.1.4 Germany Anti-Obesity Drugs Market by Distribution Channel
7.2.5.2 UK Anti-Obesity Drugs Market
7.2.5.2.1 UK Anti-Obesity Drugs Market by Drug Type
7.2.5.2.2 UK Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.2.3 UK Anti-Obesity Drugs Market by Route Of Administration
7.2.5.2.4 UK Anti-Obesity Drugs Market by Distribution Channel
7.2.5.3 France Anti-Obesity Drugs Market
7.2.5.3.1 France Anti-Obesity Drugs Market by Drug Type
7.2.5.3.2 France Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.3.3 France Anti-Obesity Drugs Market by Route Of Administration
7.2.5.3.4 France Anti-Obesity Drugs Market by Distribution Channel
7.2.5.4 Russia Anti-Obesity Drugs Market
7.2.5.4.1 Russia Anti-Obesity Drugs Market by Drug Type
7.2.5.4.2 Russia Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.4.3 Russia Anti-Obesity Drugs Market by Route Of Administration
7.2.5.4.4 Russia Anti-Obesity Drugs Market by Distribution Channel
7.2.5.5 Spain Anti-Obesity Drugs Market
7.2.5.5.1 Spain Anti-Obesity Drugs Market by Drug Type
7.2.5.5.2 Spain Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.5.3 Spain Anti-Obesity Drugs Market by Route Of Administration
7.2.5.5.4 Spain Anti-Obesity Drugs Market by Distribution Channel
7.2.5.6 Italy Anti-Obesity Drugs Market
7.2.5.6.1 Italy Anti-Obesity Drugs Market by Drug Type
7.2.5.6.2 Italy Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.6.3 Italy Anti-Obesity Drugs Market by Route Of Administration
7.2.5.6.4 Italy Anti-Obesity Drugs Market by Distribution Channel
7.2.5.7 Rest of Europe Anti-Obesity Drugs Market
7.2.5.7.1 Rest of Europe Anti-Obesity Drugs Market by Drug Type
7.2.5.7.2 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.7.3 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration
7.2.5.7.4 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel
7.3 Asia Pacific Anti-Obesity Drugs Market
7.3.1 Asia Pacific Anti-Obesity Drugs Market by Drug Type
7.3.1.1 Asia Pacific Prescription Drugs Market by Country
7.3.1.2 Asia Pacific Over The Counter Drugs Market by Country
7.3.2 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
7.3.2.1 Asia Pacific Centrally Acting Market by Country
7.3.2.2 Asia Pacific Peripherally Acting Market by Country
7.3.3 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
7.3.3.1 Asia Pacific Oral Route Market by Country
7.3.3.2 Asia Pacific Subcutaneous Route Market by Country
7.3.4 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
7.3.4.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.4.2 Asia Pacific Retail Pharmacies Market by Country
7.3.4.3 Asia Pacific Online Pharmacies Market by Country
7.3.5 Asia Pacific Anti-Obesity Drugs Market by Country
7.3.5.1 China Anti-Obesity Drugs Market
7.3.5.1.1 China Anti-Obesity Drugs Market by Drug Type
7.3.5.1.2 China Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.1.3 China Anti-Obesity Drugs Market by Route Of Administration
7.3.5.1.4 China Anti-Obesity Drugs Market by Distribution Channel
7.3.5.2 Japan Anti-Obesity Drugs Market
7.3.5.2.1 Japan Anti-Obesity Drugs Market by Drug Type
7.3.5.2.2 Japan Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.2.3 Japan Anti-Obesity Drugs Market by Route Of Administration
7.3.5.2.4 Japan Anti-Obesity Drugs Market by Distribution Channel
7.3.5.3 India Anti-Obesity Drugs Market
7.3.5.3.1 India Anti-Obesity Drugs Market by Drug Type
7.3.5.3.2 India Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.3.3 India Anti-Obesity Drugs Market by Route Of Administration
7.3.5.3.4 India Anti-Obesity Drugs Market by Distribution Channel
7.3.5.4 South Korea Anti-Obesity Drugs Market
7.3.5.4.1 South Korea Anti-Obesity Drugs Market by Drug Type
7.3.5.4.2 South Korea Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.4.3 South Korea Anti-Obesity Drugs Market by Route Of Administration
7.3.5.4.4 South Korea Anti-Obesity Drugs Market by Distribution Channel
7.3.5.5 Singapore Anti-Obesity Drugs Market
7.3.5.5.1 Singapore Anti-Obesity Drugs Market by Drug Type
7.3.5.5.2 Singapore Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.5.3 Singapore Anti-Obesity Drugs Market by Route Of Administration
7.3.5.5.4 Singapore Anti-Obesity Drugs Market by Distribution Channel
7.3.5.6 Malaysia Anti-Obesity Drugs Market
7.3.5.6.1 Malaysia Anti-Obesity Drugs Market by Drug Type
7.3.5.6.2 Malaysia Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.6.3 Malaysia Anti-Obesity Drugs Market by Route Of Administration
7.3.5.6.4 Malaysia Anti-Obesity Drugs Market by Distribution Channel
7.3.5.7 Rest of Asia Pacific Anti-Obesity Drugs Market
7.3.5.7.1 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type
7.3.5.7.2 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.7.3 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
7.3.5.7.4 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
7.4 LAMEA Anti-Obesity Drugs Market
7.4.1 LAMEA Anti-Obesity Drugs Market by Drug Type
7.4.1.1 LAMEA Prescription Drugs Market by Country
7.4.1.2 LAMEA Over The Counter Drugs Market by Country
7.4.2 LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.4.2.1 LAMEA Centrally Acting Market by Country
7.4.2.2 LAMEA Peripherally Acting Market by Country
7.4.3 LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.4.3.1 LAMEA Oral Route Market by Country
7.4.3.2 LAMEA Subcutaneous Route Market by Country
7.4.4 LAMEA Anti-Obesity Drugs Market by Distribution Channel
7.4.4.1 LAMEA Hospital Pharmacies Market by Country
7.4.4.2 LAMEA Retail Pharmacies Market by Country
7.4.4.3 LAMEA Online Pharmacies Market by Country
7.4.5 LAMEA Anti-Obesity Drugs Market by Country
7.4.5.1 Brazil Anti-Obesity Drugs Market
7.4.5.1.1 Brazil Anti-Obesity Drugs Market by Drug Type
7.4.5.1.2 Brazil Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.1.3 Brazil Anti-Obesity Drugs Market by Route Of Administration
7.4.5.1.4 Brazil Anti-Obesity Drugs Market by Distribution Channel
7.4.5.2 Argentina Anti-Obesity Drugs Market
7.4.5.2.1 Argentina Anti-Obesity Drugs Market by Drug Type
7.4.5.2.2 Argentina Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.2.3 Argentina Anti-Obesity Drugs Market by Route Of Administration
7.4.5.2.4 Argentina Anti-Obesity Drugs Market by Distribution Channel
7.4.5.3 UAE Anti-Obesity Drugs Market
7.4.5.3.1 UAE Anti-Obesity Drugs Market by Drug Type
7.4.5.3.2 UAE Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.3.3 UAE Anti-Obesity Drugs Market by Route Of Administration
7.4.5.3.4 UAE Anti-Obesity Drugs Market by Distribution Channel
7.4.5.4 Saudi Arabia Anti-Obesity Drugs Market
7.4.5.4.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
7.4.5.4.2 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.4.3 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration
7.4.5.4.4 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel
7.4.5.5 South Africa Anti-Obesity Drugs Market
7.4.5.5.1 South Africa Anti-Obesity Drugs Market by Drug Type
7.4.5.5.2 South Africa Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.5.3 South Africa Anti-Obesity Drugs Market by Route Of Administration
7.4.5.5.4 South Africa Anti-Obesity Drugs Market by Distribution Channel
7.4.5.6 Nigeria Anti-Obesity Drugs Market
7.4.5.6.1 Nigeria Anti-Obesity Drugs Market by Drug Type
7.4.5.6.2 Nigeria Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.6.3 Nigeria Anti-Obesity Drugs Market by Route Of Administration
7.4.5.6.4 Nigeria Anti-Obesity Drugs Market by Distribution Channel
7.4.5.7 Rest of LAMEA Anti-Obesity Drugs Market
7.4.5.7.1 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type
7.4.5.7.2 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.7.3 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.4.5.7.4 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Boehringer Ingelheim International Gmbh
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 GlaxoSmithKline PLC (GSK)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Novo Nordisk A/S
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental & Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Rhythm Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Gelesis Holdings Inc (PureTech Health)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals and Trials:
8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Acquisition and Mergers:
8.8 Vivus LLC
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
8.9.1 Company Overview
8.10. KVK Tech, Inc.
8.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Anti-Obesity Drugs Market, by Drug Type
1.4.2 Global Anti-Obesity Drugs Market, by Mechanism of Action
1.4.3 Global Anti-Obesity Drugs Market, by Route Of Administration
1.4.4 Global Anti-Obesity Drugs Market, by Distribution Channel
1.4.5 Global Anti-Obesity Drugs Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Anti-Obesity Drugs Market by Drug Type
3.1 Global Prescription Drugs Market by Region
3.2 Global Over The Counter Drugs Market by Region
Chapter 4. Global Anti-Obesity Drugs Market by Mechanism of Action
4.1 Global Centrally Acting Market by Region
4.2 Global Peripherally Acting Market by Region
Chapter 5. Global Anti-Obesity Drugs Market by Route Of Administration
5.1 Global Oral Route Market by Region
5.2 Global Subcutaneous Route Market by Region
Chapter 6. Global Anti-Obesity Drugs Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region
Chapter 7. Global Anti-Obesity Drugs Market by Region
7.1 North America Anti-Obesity Drugs Market
7.1.1 North America Anti-Obesity Drugs Market by Drug Type
7.1.1.1 North America Prescription Drugs Market by Country
7.1.1.2 North America Over The Counter Drugs Market by Country
7.1.2 North America Anti-Obesity Drugs Market by Mechanism of Action
7.1.2.1 North America Centrally Acting Market by Country
7.1.2.2 North America Peripherally Acting Market by Country
7.1.3 North America Anti-Obesity Drugs Market by Route Of Administration
7.1.3.1 North America Oral Route Market by Country
7.1.3.2 North America Subcutaneous Route Market by Country
7.1.4 North America Anti-Obesity Drugs Market by Distribution Channel
7.1.4.1 North America Hospital Pharmacies Market by Country
7.1.4.2 North America Retail Pharmacies Market by Country
7.1.4.3 North America Online Pharmacies Market by Country
7.1.5 North America Anti-Obesity Drugs Market by Country
7.1.5.1 US Anti-Obesity Drugs Market
7.1.5.1.1 US Anti-Obesity Drugs Market by Drug Type
7.1.5.1.2 US Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.1.3 US Anti-Obesity Drugs Market by Route Of Administration
7.1.5.1.4 US Anti-Obesity Drugs Market by Distribution Channel
7.1.5.2 Canada Anti-Obesity Drugs Market
7.1.5.2.1 Canada Anti-Obesity Drugs Market by Drug Type
7.1.5.2.2 Canada Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.2.3 Canada Anti-Obesity Drugs Market by Route Of Administration
7.1.5.2.4 Canada Anti-Obesity Drugs Market by Distribution Channel
7.1.5.3 Mexico Anti-Obesity Drugs Market
7.1.5.3.1 Mexico Anti-Obesity Drugs Market by Drug Type
7.1.5.3.2 Mexico Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.3.3 Mexico Anti-Obesity Drugs Market by Route Of Administration
7.1.5.3.4 Mexico Anti-Obesity Drugs Market by Distribution Channel
7.1.5.4 Rest of North America Anti-Obesity Drugs Market
7.1.5.4.1 Rest of North America Anti-Obesity Drugs Market by Drug Type
7.1.5.4.2 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action
7.1.5.4.3 Rest of North America Anti-Obesity Drugs Market by Route Of Administration
7.1.5.4.4 Rest of North America Anti-Obesity Drugs Market by Distribution Channel
7.2 Europe Anti-Obesity Drugs Market
7.2.1 Europe Anti-Obesity Drugs Market by Drug Type
7.2.1.1 Europe Prescription Drugs Market by Country
7.2.1.2 Europe Over The Counter Drugs Market by Country
7.2.2 Europe Anti-Obesity Drugs Market by Mechanism of Action
7.2.2.1 Europe Centrally Acting Market by Country
7.2.2.2 Europe Peripherally Acting Market by Country
7.2.3 Europe Anti-Obesity Drugs Market by Route Of Administration
7.2.3.1 Europe Oral Route Market by Country
7.2.3.2 Europe Subcutaneous Route Market by Country
7.2.4 Europe Anti-Obesity Drugs Market by Distribution Channel
7.2.4.1 Europe Hospital Pharmacies Market by Country
7.2.4.2 Europe Retail Pharmacies Market by Country
7.2.4.3 Europe Online Pharmacies Market by Country
7.2.5 Europe Anti-Obesity Drugs Market by Country
7.2.5.1 Germany Anti-Obesity Drugs Market
7.2.5.1.1 Germany Anti-Obesity Drugs Market by Drug Type
7.2.5.1.2 Germany Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.1.3 Germany Anti-Obesity Drugs Market by Route Of Administration
7.2.5.1.4 Germany Anti-Obesity Drugs Market by Distribution Channel
7.2.5.2 UK Anti-Obesity Drugs Market
7.2.5.2.1 UK Anti-Obesity Drugs Market by Drug Type
7.2.5.2.2 UK Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.2.3 UK Anti-Obesity Drugs Market by Route Of Administration
7.2.5.2.4 UK Anti-Obesity Drugs Market by Distribution Channel
7.2.5.3 France Anti-Obesity Drugs Market
7.2.5.3.1 France Anti-Obesity Drugs Market by Drug Type
7.2.5.3.2 France Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.3.3 France Anti-Obesity Drugs Market by Route Of Administration
7.2.5.3.4 France Anti-Obesity Drugs Market by Distribution Channel
7.2.5.4 Russia Anti-Obesity Drugs Market
7.2.5.4.1 Russia Anti-Obesity Drugs Market by Drug Type
7.2.5.4.2 Russia Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.4.3 Russia Anti-Obesity Drugs Market by Route Of Administration
7.2.5.4.4 Russia Anti-Obesity Drugs Market by Distribution Channel
7.2.5.5 Spain Anti-Obesity Drugs Market
7.2.5.5.1 Spain Anti-Obesity Drugs Market by Drug Type
7.2.5.5.2 Spain Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.5.3 Spain Anti-Obesity Drugs Market by Route Of Administration
7.2.5.5.4 Spain Anti-Obesity Drugs Market by Distribution Channel
7.2.5.6 Italy Anti-Obesity Drugs Market
7.2.5.6.1 Italy Anti-Obesity Drugs Market by Drug Type
7.2.5.6.2 Italy Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.6.3 Italy Anti-Obesity Drugs Market by Route Of Administration
7.2.5.6.4 Italy Anti-Obesity Drugs Market by Distribution Channel
7.2.5.7 Rest of Europe Anti-Obesity Drugs Market
7.2.5.7.1 Rest of Europe Anti-Obesity Drugs Market by Drug Type
7.2.5.7.2 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action
7.2.5.7.3 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration
7.2.5.7.4 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel
7.3 Asia Pacific Anti-Obesity Drugs Market
7.3.1 Asia Pacific Anti-Obesity Drugs Market by Drug Type
7.3.1.1 Asia Pacific Prescription Drugs Market by Country
7.3.1.2 Asia Pacific Over The Counter Drugs Market by Country
7.3.2 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
7.3.2.1 Asia Pacific Centrally Acting Market by Country
7.3.2.2 Asia Pacific Peripherally Acting Market by Country
7.3.3 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
7.3.3.1 Asia Pacific Oral Route Market by Country
7.3.3.2 Asia Pacific Subcutaneous Route Market by Country
7.3.4 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
7.3.4.1 Asia Pacific Hospital Pharmacies Market by Country
7.3.4.2 Asia Pacific Retail Pharmacies Market by Country
7.3.4.3 Asia Pacific Online Pharmacies Market by Country
7.3.5 Asia Pacific Anti-Obesity Drugs Market by Country
7.3.5.1 China Anti-Obesity Drugs Market
7.3.5.1.1 China Anti-Obesity Drugs Market by Drug Type
7.3.5.1.2 China Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.1.3 China Anti-Obesity Drugs Market by Route Of Administration
7.3.5.1.4 China Anti-Obesity Drugs Market by Distribution Channel
7.3.5.2 Japan Anti-Obesity Drugs Market
7.3.5.2.1 Japan Anti-Obesity Drugs Market by Drug Type
7.3.5.2.2 Japan Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.2.3 Japan Anti-Obesity Drugs Market by Route Of Administration
7.3.5.2.4 Japan Anti-Obesity Drugs Market by Distribution Channel
7.3.5.3 India Anti-Obesity Drugs Market
7.3.5.3.1 India Anti-Obesity Drugs Market by Drug Type
7.3.5.3.2 India Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.3.3 India Anti-Obesity Drugs Market by Route Of Administration
7.3.5.3.4 India Anti-Obesity Drugs Market by Distribution Channel
7.3.5.4 South Korea Anti-Obesity Drugs Market
7.3.5.4.1 South Korea Anti-Obesity Drugs Market by Drug Type
7.3.5.4.2 South Korea Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.4.3 South Korea Anti-Obesity Drugs Market by Route Of Administration
7.3.5.4.4 South Korea Anti-Obesity Drugs Market by Distribution Channel
7.3.5.5 Singapore Anti-Obesity Drugs Market
7.3.5.5.1 Singapore Anti-Obesity Drugs Market by Drug Type
7.3.5.5.2 Singapore Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.5.3 Singapore Anti-Obesity Drugs Market by Route Of Administration
7.3.5.5.4 Singapore Anti-Obesity Drugs Market by Distribution Channel
7.3.5.6 Malaysia Anti-Obesity Drugs Market
7.3.5.6.1 Malaysia Anti-Obesity Drugs Market by Drug Type
7.3.5.6.2 Malaysia Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.6.3 Malaysia Anti-Obesity Drugs Market by Route Of Administration
7.3.5.6.4 Malaysia Anti-Obesity Drugs Market by Distribution Channel
7.3.5.7 Rest of Asia Pacific Anti-Obesity Drugs Market
7.3.5.7.1 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type
7.3.5.7.2 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
7.3.5.7.3 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
7.3.5.7.4 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
7.4 LAMEA Anti-Obesity Drugs Market
7.4.1 LAMEA Anti-Obesity Drugs Market by Drug Type
7.4.1.1 LAMEA Prescription Drugs Market by Country
7.4.1.2 LAMEA Over The Counter Drugs Market by Country
7.4.2 LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.4.2.1 LAMEA Centrally Acting Market by Country
7.4.2.2 LAMEA Peripherally Acting Market by Country
7.4.3 LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.4.3.1 LAMEA Oral Route Market by Country
7.4.3.2 LAMEA Subcutaneous Route Market by Country
7.4.4 LAMEA Anti-Obesity Drugs Market by Distribution Channel
7.4.4.1 LAMEA Hospital Pharmacies Market by Country
7.4.4.2 LAMEA Retail Pharmacies Market by Country
7.4.4.3 LAMEA Online Pharmacies Market by Country
7.4.5 LAMEA Anti-Obesity Drugs Market by Country
7.4.5.1 Brazil Anti-Obesity Drugs Market
7.4.5.1.1 Brazil Anti-Obesity Drugs Market by Drug Type
7.4.5.1.2 Brazil Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.1.3 Brazil Anti-Obesity Drugs Market by Route Of Administration
7.4.5.1.4 Brazil Anti-Obesity Drugs Market by Distribution Channel
7.4.5.2 Argentina Anti-Obesity Drugs Market
7.4.5.2.1 Argentina Anti-Obesity Drugs Market by Drug Type
7.4.5.2.2 Argentina Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.2.3 Argentina Anti-Obesity Drugs Market by Route Of Administration
7.4.5.2.4 Argentina Anti-Obesity Drugs Market by Distribution Channel
7.4.5.3 UAE Anti-Obesity Drugs Market
7.4.5.3.1 UAE Anti-Obesity Drugs Market by Drug Type
7.4.5.3.2 UAE Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.3.3 UAE Anti-Obesity Drugs Market by Route Of Administration
7.4.5.3.4 UAE Anti-Obesity Drugs Market by Distribution Channel
7.4.5.4 Saudi Arabia Anti-Obesity Drugs Market
7.4.5.4.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
7.4.5.4.2 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.4.3 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration
7.4.5.4.4 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel
7.4.5.5 South Africa Anti-Obesity Drugs Market
7.4.5.5.1 South Africa Anti-Obesity Drugs Market by Drug Type
7.4.5.5.2 South Africa Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.5.3 South Africa Anti-Obesity Drugs Market by Route Of Administration
7.4.5.5.4 South Africa Anti-Obesity Drugs Market by Distribution Channel
7.4.5.6 Nigeria Anti-Obesity Drugs Market
7.4.5.6.1 Nigeria Anti-Obesity Drugs Market by Drug Type
7.4.5.6.2 Nigeria Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.6.3 Nigeria Anti-Obesity Drugs Market by Route Of Administration
7.4.5.6.4 Nigeria Anti-Obesity Drugs Market by Distribution Channel
7.4.5.7 Rest of LAMEA Anti-Obesity Drugs Market
7.4.5.7.1 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type
7.4.5.7.2 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action
7.4.5.7.3 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration
7.4.5.7.4 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Boehringer Ingelheim International Gmbh
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 GlaxoSmithKline PLC (GSK)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Novo Nordisk A/S
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental & Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Rhythm Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Gelesis Holdings Inc (PureTech Health)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals and Trials:
8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Acquisition and Mergers:
8.8 Vivus LLC
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
8.9.1 Company Overview
8.10. KVK Tech, Inc.
8.10.1 Company Overview
List of Tables
TABLE 1 Global Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 2 Global Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 3 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Global Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 Global Prescription Drugs Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Prescription Drugs Market by Region, 2023 - 2029, USD Million
TABLE 7 Global Over The Counter Drugs Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Over The Counter Drugs Market by Region, 2023 - 2029, USD Million
TABLE 9 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 10 Global Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 11 Global Centrally Acting Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Centrally Acting Market by Region, 2023 - 2029, USD Million
TABLE 13 Global Peripherally Acting Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Peripherally Acting Market by Region, 2023 - 2029, USD Million
TABLE 15 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 16 Global Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 17 Global Oral Route Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Oral Route Market by Region, 2023 - 2029, USD Million
TABLE 19 Global Subcutaneous Route Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Subcutaneous Route Market by Region, 2023 - 2029, USD Million
TABLE 21 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Global Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 25 Global Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Retail Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 27 Global Online Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Online Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 29 Global Anti-Obesity Drugs Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Anti-Obesity Drugs Market by Region, 2023 - 2029, USD Million
TABLE 31 North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 32 North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 33 North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 34 North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 35 North America Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 37 North America Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 39 North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 40 North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 41 North America Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 43 North America Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 45 North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 46 North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 47 North America Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 49 North America Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 51 North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 53 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 55 North America Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 57 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 58 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 59 North America Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 61 US Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 62 US Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 63 US Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 US Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 US Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 66 US Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 67 US Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 68 US Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 69 US Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 US Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 Canada Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 72 Canada Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 73 Canada Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 74 Canada Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 75 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 76 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 77 Canada Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 78 Canada Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 79 Canada Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Canada Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 81 Mexico Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 82 Mexico Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 83 Mexico Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 84 Mexico Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 85 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 86 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 87 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 88 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 89 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 91 Rest of North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 92 Rest of North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 93 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 94 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 95 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 96 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 97 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 98 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 99 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 100 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 101 Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 102 Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 103 Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 104 Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 105 Europe Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 106 Europe Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 107 Europe Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 109 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 110 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 111 Europe Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 112 Europe Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 113 Europe Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 115 Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 116 Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 117 Europe Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 118 Europe Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 119 Europe Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 121 Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 122 Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 123 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 124 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 125 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 126 Europe Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 127 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 128 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 129 Europe Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 130 Europe Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 131 Germany Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 132 Germany Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 133 Germany Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 134 Germany Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 135 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 136 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 137 Germany Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 138 Germany Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 139 Germany Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 Germany Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 141 UK Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 142 UK Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 143 UK Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 144 UK Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 145 UK Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 146 UK Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 147 UK Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 148 UK Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 149 UK Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 150 UK Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 151 France Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 152 France Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 153 France Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 154 France Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 155 France Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 156 France Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 157 France Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 158 France Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 159 France Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 160 France Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 161 Russia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 162 Russia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 163 Russia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 164 Russia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 165 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 166 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 167 Russia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 168 Russia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 169 Russia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 170 Russia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 171 Spain Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 172 Spain Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 173 Spain Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 174 Spain Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 175 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 176 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 177 Spain Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 178 Spain Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 179 Spain Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 180 Spain Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 181 Italy Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 182 Italy Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 183 Italy Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 184 Italy Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 185 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 186 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 187 Italy Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 188 Italy Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 189 Italy Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 190 Italy Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 191 Rest of Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 192 Rest of Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 193 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 194 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 195 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 196 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 197 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 198 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 199 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 200 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 201 Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 203 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 205 Asia Pacific Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 207 Asia Pacific Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 209 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 210 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 211 Asia Pacific Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 212 Asia Pacific Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 213 Asia Pacific Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 215 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 217 Asia Pacific Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 219 Asia Pacific Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 221 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 222 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 223 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 224 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 225 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 226 Asia Pacific Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 227 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 228 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 229 Asia Pacific Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 230 Asia Pacific Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 231 China Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 232 China Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 233 China Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 234 China Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 235 China Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 236 China Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 237 China Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 238 China Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 239 China Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 240 China Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 241 Japan Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 242 Japan Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 243 Japan Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 244 Japan Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 245 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 246 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 247 Japan Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 248 Japan Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 249 Japan Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 250 Japan Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 251 India Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 252 India Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 253 India Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 254 India Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 255 India Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 256 India Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 257 India Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 258 India Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 259 India Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 260 India Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 261 South Korea Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 262 South Korea Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 263 South Korea Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 264 South Korea Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 265 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 266 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 267 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 268 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 269 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 270 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 271 Singapore Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 272 Singapore Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 273 Singapore Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 274 Singapore Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 275 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 276 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 277 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 278 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 279 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 280 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 281 Malaysia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 282 Malaysia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 283 Malaysia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 284 Malaysia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 285 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 286 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 287 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 288 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 289 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 290 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 291 Rest of Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 292 Rest of Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 293 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 294 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 295 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 296 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 297 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 298 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 299 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 300 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 301 LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 302 LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 303 LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 304 LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 305 LAMEA Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 306 LAMEA Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 307 LAMEA Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 308 LAMEA Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 309 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 310 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 311 LAMEA Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 312 LAMEA Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 313 LAMEA Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 314 LAMEA Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 315 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 316 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 317 LAMEA Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 318 LAMEA Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 319 LAMEA Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 320 LAMEA Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 321 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 322 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 323 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 324 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 325 LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 326 LAMEA Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 327 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 328 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 329 LAMEA Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 330 LAMEA Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 331 Brazil Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 332 Brazil Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 333 Brazil Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 334 Brazil Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 335 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 336 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 337 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 338 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 339 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 340 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 341 Argentina Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 342 Argentina Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 343 Argentina Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 344 Argentina Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 345 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 346 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 347 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 348 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 349 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 350 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 351 UAE Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 352 UAE Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 353 UAE Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 354 UAE Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 355 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 356 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 357 UAE Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 358 UAE Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 359 UAE Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 360 UAE Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 361 Saudi Arabia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 362 Saudi Arabia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 363 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 364 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 365 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 366 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 367 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 368 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 369 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 370 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 371 South Africa Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 372 South Africa Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 373 South Africa Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 374 South Africa Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 375 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 376 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 377 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 378 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 379 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 380 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 381 Nigeria Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 382 Nigeria Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 383 Nigeria Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 384 Nigeria Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 385 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 386 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 387 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 388 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 389 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 390 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 391 Rest of LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 392 Rest of LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 393 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 394 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 395 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 396 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 397 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 398 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 399 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 400 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 401 Key Information – Pfizer, Inc.
TABLE 402 Key Information – Boehringer Ingelheim International GmbH
TABLE 403 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 404 Key information – Novo Nordisk A/S
TABLE 405 Key Information – Rhythm Pharmaceuticals, Inc
TABLE 406 Key Information – Gelesis Holdings Inc.
TABLE 407 Key Information – Currax Pharmaceuticals LLC
TABLE 408 Key Information – Vivus LLC
TABLE 409 Key Information – CHEPLAPHARM Arzneimittel GmbH
TABLE 410 Key Information – KVK Tech, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Anti-Obesity Drugs Market share by Drug Type, 2022
FIG 3 Global Anti-Obesity Drugs Market share by Drug Type, 2029
FIG 4 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 5 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2022
FIG 6 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2029
FIG 7 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2029, USD Million
FIG 8 Global Anti-Obesity Drugs Market share by Route Of Administration, 2022
FIG 9 Global Anti-Obesity Drugs Market share by Route Of Administration, 2029
FIG 10 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2029, USD Million
FIG 11 Global Anti-Obesity Drugs Market share by Distribution Channel, 2022
FIG 12 Global Anti-Obesity Drugs Market share by Distribution Channel, 2029
FIG 13 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 14 Global Anti-Obesity Drugs Market share by Region, 2022
FIG 15 Global Anti-Obesity Drugs Market share by Region, 2029
FIG 16 Global Anti-Obesity Drugs Market by Region, 2019 - 2029, USD Million
TABLE 2 Global Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 3 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 Global Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 Global Prescription Drugs Market by Region, 2019 - 2022, USD Million
TABLE 6 Global Prescription Drugs Market by Region, 2023 - 2029, USD Million
TABLE 7 Global Over The Counter Drugs Market by Region, 2019 - 2022, USD Million
TABLE 8 Global Over The Counter Drugs Market by Region, 2023 - 2029, USD Million
TABLE 9 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 10 Global Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 11 Global Centrally Acting Market by Region, 2019 - 2022, USD Million
TABLE 12 Global Centrally Acting Market by Region, 2023 - 2029, USD Million
TABLE 13 Global Peripherally Acting Market by Region, 2019 - 2022, USD Million
TABLE 14 Global Peripherally Acting Market by Region, 2023 - 2029, USD Million
TABLE 15 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 16 Global Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 17 Global Oral Route Market by Region, 2019 - 2022, USD Million
TABLE 18 Global Oral Route Market by Region, 2023 - 2029, USD Million
TABLE 19 Global Subcutaneous Route Market by Region, 2019 - 2022, USD Million
TABLE 20 Global Subcutaneous Route Market by Region, 2023 - 2029, USD Million
TABLE 21 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Global Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 24 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 25 Global Retail Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 26 Global Retail Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 27 Global Online Pharmacies Market by Region, 2019 - 2022, USD Million
TABLE 28 Global Online Pharmacies Market by Region, 2023 - 2029, USD Million
TABLE 29 Global Anti-Obesity Drugs Market by Region, 2019 - 2022, USD Million
TABLE 30 Global Anti-Obesity Drugs Market by Region, 2023 - 2029, USD Million
TABLE 31 North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 32 North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 33 North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 34 North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 35 North America Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 37 North America Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 39 North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 40 North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 41 North America Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 43 North America Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 45 North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 46 North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 47 North America Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 48 North America Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 49 North America Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 50 North America Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 51 North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 52 North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 53 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 54 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 55 North America Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 56 North America Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 57 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 58 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 59 North America Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 60 North America Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 61 US Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 62 US Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 63 US Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 64 US Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 65 US Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 66 US Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 67 US Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 68 US Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 69 US Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 US Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 Canada Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 72 Canada Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 73 Canada Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 74 Canada Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 75 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 76 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 77 Canada Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 78 Canada Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 79 Canada Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 80 Canada Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 81 Mexico Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 82 Mexico Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 83 Mexico Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 84 Mexico Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 85 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 86 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 87 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 88 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 89 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 90 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 91 Rest of North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 92 Rest of North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 93 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 94 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 95 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 96 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 97 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 98 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 99 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 100 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 101 Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 102 Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 103 Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 104 Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 105 Europe Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 106 Europe Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 107 Europe Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 108 Europe Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 109 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 110 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 111 Europe Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 112 Europe Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 113 Europe Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 114 Europe Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 115 Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 116 Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 117 Europe Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 118 Europe Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 119 Europe Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 120 Europe Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 121 Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 122 Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 123 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 124 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 125 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 126 Europe Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 127 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 128 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 129 Europe Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 130 Europe Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 131 Germany Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 132 Germany Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 133 Germany Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 134 Germany Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 135 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 136 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 137 Germany Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 138 Germany Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 139 Germany Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 Germany Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 141 UK Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 142 UK Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 143 UK Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 144 UK Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 145 UK Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 146 UK Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 147 UK Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 148 UK Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 149 UK Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 150 UK Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 151 France Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 152 France Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 153 France Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 154 France Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 155 France Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 156 France Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 157 France Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 158 France Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 159 France Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 160 France Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 161 Russia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 162 Russia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 163 Russia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 164 Russia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 165 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 166 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 167 Russia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 168 Russia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 169 Russia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 170 Russia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 171 Spain Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 172 Spain Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 173 Spain Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 174 Spain Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 175 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 176 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 177 Spain Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 178 Spain Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 179 Spain Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 180 Spain Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 181 Italy Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 182 Italy Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 183 Italy Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 184 Italy Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 185 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 186 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 187 Italy Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 188 Italy Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 189 Italy Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 190 Italy Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 191 Rest of Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 192 Rest of Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 193 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 194 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 195 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 196 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 197 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 198 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 199 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 200 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 201 Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 202 Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 203 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 204 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 205 Asia Pacific Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 206 Asia Pacific Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 207 Asia Pacific Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 208 Asia Pacific Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 209 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 210 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 211 Asia Pacific Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 212 Asia Pacific Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 213 Asia Pacific Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 214 Asia Pacific Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 215 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 216 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 217 Asia Pacific Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 218 Asia Pacific Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 219 Asia Pacific Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 220 Asia Pacific Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 221 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 222 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 223 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 224 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 225 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 226 Asia Pacific Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 227 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 228 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 229 Asia Pacific Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 230 Asia Pacific Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 231 China Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 232 China Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 233 China Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 234 China Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 235 China Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 236 China Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 237 China Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 238 China Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 239 China Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 240 China Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 241 Japan Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 242 Japan Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 243 Japan Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 244 Japan Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 245 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 246 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 247 Japan Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 248 Japan Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 249 Japan Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 250 Japan Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 251 India Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 252 India Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 253 India Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 254 India Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 255 India Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 256 India Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 257 India Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 258 India Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 259 India Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 260 India Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 261 South Korea Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 262 South Korea Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 263 South Korea Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 264 South Korea Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 265 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 266 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 267 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 268 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 269 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 270 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 271 Singapore Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 272 Singapore Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 273 Singapore Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 274 Singapore Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 275 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 276 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 277 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 278 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 279 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 280 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 281 Malaysia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 282 Malaysia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 283 Malaysia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 284 Malaysia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 285 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 286 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 287 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 288 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 289 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 290 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 291 Rest of Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 292 Rest of Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 293 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 294 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 295 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 296 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 297 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 298 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 299 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 300 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 301 LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 302 LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 303 LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 304 LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 305 LAMEA Prescription Drugs Market by Country, 2019 - 2022, USD Million
TABLE 306 LAMEA Prescription Drugs Market by Country, 2023 - 2029, USD Million
TABLE 307 LAMEA Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
TABLE 308 LAMEA Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
TABLE 309 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 310 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 311 LAMEA Centrally Acting Market by Country, 2019 - 2022, USD Million
TABLE 312 LAMEA Centrally Acting Market by Country, 2023 - 2029, USD Million
TABLE 313 LAMEA Peripherally Acting Market by Country, 2019 - 2022, USD Million
TABLE 314 LAMEA Peripherally Acting Market by Country, 2023 - 2029, USD Million
TABLE 315 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 316 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 317 LAMEA Oral Route Market by Country, 2019 - 2022, USD Million
TABLE 318 LAMEA Oral Route Market by Country, 2023 - 2029, USD Million
TABLE 319 LAMEA Subcutaneous Route Market by Country, 2019 - 2022, USD Million
TABLE 320 LAMEA Subcutaneous Route Market by Country, 2023 - 2029, USD Million
TABLE 321 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 322 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 323 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 324 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 325 LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 326 LAMEA Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 327 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 328 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 329 LAMEA Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
TABLE 330 LAMEA Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
TABLE 331 Brazil Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 332 Brazil Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 333 Brazil Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 334 Brazil Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 335 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 336 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 337 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 338 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 339 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 340 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 341 Argentina Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 342 Argentina Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 343 Argentina Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 344 Argentina Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 345 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 346 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 347 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 348 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 349 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 350 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 351 UAE Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 352 UAE Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 353 UAE Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 354 UAE Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 355 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 356 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 357 UAE Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 358 UAE Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 359 UAE Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 360 UAE Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 361 Saudi Arabia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 362 Saudi Arabia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 363 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 364 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 365 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 366 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 367 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 368 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 369 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 370 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 371 South Africa Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 372 South Africa Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 373 South Africa Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 374 South Africa Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 375 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 376 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 377 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 378 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 379 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 380 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 381 Nigeria Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 382 Nigeria Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 383 Nigeria Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 384 Nigeria Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 385 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 386 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 387 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 388 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 389 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 390 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 391 Rest of LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
TABLE 392 Rest of LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
TABLE 393 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 394 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 395 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
TABLE 396 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
TABLE 397 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
TABLE 398 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
TABLE 399 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 400 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 401 Key Information – Pfizer, Inc.
TABLE 402 Key Information – Boehringer Ingelheim International GmbH
TABLE 403 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 404 Key information – Novo Nordisk A/S
TABLE 405 Key Information – Rhythm Pharmaceuticals, Inc
TABLE 406 Key Information – Gelesis Holdings Inc.
TABLE 407 Key Information – Currax Pharmaceuticals LLC
TABLE 408 Key Information – Vivus LLC
TABLE 409 Key Information – CHEPLAPHARM Arzneimittel GmbH
TABLE 410 Key Information – KVK Tech, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Anti-Obesity Drugs Market share by Drug Type, 2022
FIG 3 Global Anti-Obesity Drugs Market share by Drug Type, 2029
FIG 4 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 5 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2022
FIG 6 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2029
FIG 7 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2029, USD Million
FIG 8 Global Anti-Obesity Drugs Market share by Route Of Administration, 2022
FIG 9 Global Anti-Obesity Drugs Market share by Route Of Administration, 2029
FIG 10 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2029, USD Million
FIG 11 Global Anti-Obesity Drugs Market share by Distribution Channel, 2022
FIG 12 Global Anti-Obesity Drugs Market share by Distribution Channel, 2029
FIG 13 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 14 Global Anti-Obesity Drugs Market share by Region, 2022
FIG 15 Global Anti-Obesity Drugs Market share by Region, 2029
FIG 16 Global Anti-Obesity Drugs Market by Region, 2019 - 2029, USD Million